Skip to main content
Clinical Trials/NCT04848025
NCT04848025
Recruiting
Not Applicable

Treatment of Central Airway Stenoses Using Computer-Assisted Customized 3d Stents TATUM (Three-dimensional Airway Tailored Stent Using Computer-aided Modeling)

University Hospital, Toulouse1 site in 1 country30 target enrollmentJune 17, 2021
ConditionsAirway Disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Airway Disease
Sponsor
University Hospital, Toulouse
Enrollment
30
Locations
1
Primary Endpoint
Percentage of procedures with clinical improvement of the dyspnea
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Airway stenting is usually efficient to treat central airway obstruction but can lead to severe and potentially lethal complications (stent migration, obstructive granuloma, perforation, and hemoptysis).

3D customized airway stents (computer-aided conception using CT-scan data), perfectly suited to airway anatomy, should improve the tolerance and safety of airway stenting.

We demonstrated in a previous pilot study, dedicated to patients with anatomically complex stenoses the safety of 3D patient-specific stents. These appealing results in highly complex situations suggest the need to evaluate these devices in more common situations.

In this study we aim to test our new generation stents in all patients planned for airway stenting. After computer-assisted segmentation of airways (VGStudioMAX 3.0 software), the stenosis is virtually corrected, leading to the conception of a virtual stent (AnatomikModeling, Toulouse), allowing for the fabrication of a mold using a 3D printer. The stent is then built and sterilized (NOVATECH, Berlin) and inserted during rigid bronchoscopy.

Close follow up is then conducted, including clinical evaluation after one week, three, six and 12 months; spirometry at one week, 3 months, 6 months and 12 months and chest CT-scan at one week.

Registry
clinicaltrials.gov
Start Date
June 17, 2021
End Date
December 2025
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \>18 years
  • Informed consent
  • Complex, proximal and symptomatic (dyspnea, cough, peak flow \< 50%, FEV1 \< 50% or post-stenotic infection) airway stenosis

Exclusion Criteria

  • Acute respiratory distress, mechanical ventilation
  • Contraindication to rigid bronchoscopy (severe and irreversible coagulation disorders)
  • Pregnancy

Outcomes

Primary Outcomes

Percentage of procedures with clinical improvement of the dyspnea

Time Frame: 12 months

Percentage of procedures with clinical improvement of the dyspnea with questionnaires of Borg, modified Medical Research Council (mMRC), and Dyspnea 12

Percentage of procedures with clinical improvement of quality of life

Time Frame: 12 months

Percentage of procedures with clinical improvement of quality of life with the VQ11 questionnaire

Secondary Outcomes

  • Percentage of procedures with clinical and functional improvement(12 months)
  • Percentage of procedures without complications(12 months)
  • Percentage of procedures with functional improvement(1 seconde)
  • Percentage of procedures with congruence of the stent(1 week)

Study Sites (1)

Loading locations...

Similar Trials